CERS vs CNC · rev $201.3M vs P/E 8.4, rev $163.07B
Cerus Corporation (CERS) versus Centene Corp (CNC) — a side-by-side from cached financials, not a winner call.
Cerus Corporation (CERS) is a medical devices company listed on US.
Centene Corp (CNC) is a healthcare plans company listed on US.
Latest reported CERS revenue for 2024-12-31 was $201.3M. Net income was -$21.0M. Revenue was up 7.8% from 2023-12-31 to 2024-12-31. CERS currently screens at market cap $294.4M.
Latest reported CNC revenue for 2024-12-31 was $163.07B. Net income was $3.29B. Revenue was up 5.9% from 2023-12-31 to 2024-12-31. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
CERS currently screens at market cap $294.4M. CNC currently screens at market cap $28.19B and trailing P/E 8.4.
Not investment advice. Open the CERS and CNC stock pages for the full models.
Not investment advice.